CNBC's Fed Survey shows market pros aren't very confident the Fed can end its easy money polices without a market crash, a recession or bad inflation.
Merck reported better-than-expected results, with sales of newer drugs offsetting declining sales of drugs facing generic competition.
Pfizer reported higher-than-expected second-quarter earnings, helped by growing sales of its cancer medicines.
An agency that enforces antimonopoly laws visited company offices in four cities, as the country more closely scrutinizes multinational companies.
Get the best of CNBC in your inbox
The Gherkin, one of London’s most recognizable buildings, is up for sale, and is expected to reach £650 million plus, according to property sources.
Dennis Gartman of "The Gartman Letter" says the action in El Pollo Loco could be indicative of a market top.
After news of the monster dollar-store merger, here's the thing no one seems to be talking about, says retail analyst Brian Sozzi.
CNBC's David Faber explains the shareholder benefit after Windstream announced it is spinning off its assets into a publicly traded REIT.
Vote now: A personal assistant A.I. robot vs. a no-fee smartphone controlled security system.
Kurt Kuehn, UPS CFO, discusses the company's quarterly earnings and spending initiatives that increased operating expenses but will provide long-term benefits. Kuehn also shares his opinions on America's corporate tax structure.